Oramed Pharmaceuticals Inc.
- Last sale
- Nov 12, 2026 · -2.30%
- Market cap
- $175.25M
- 43.49M shares
- Filings
- 951
FY 2025+49.3% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026−15.6% FY25 yoy
- $175.25M
- 2.7×
- 87.6×
- 0.5×
- -5.22%
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of record
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $2,000,000 | reported | |
| FY 2023 | 2023-12-31 | $1,340,000 | reported | |
| FY 2022 | 2022-12-31 | $2,703,000 | reported | |
| FY 2021 | 2021-08-31 | $2,703,000 | reported | |
| FY 2020 | 2020-08-31 | $2,710,000 | reported | |
| FY 2019 | 2019-08-31 | $2,703,000 | reported | |
| FY 2018 | 2018-08-31 | $2,449,000 | reported | |
| FY 2017 | 2017-08-31 | $2,456,000 | reported | |
| FY 2016 | 2016-08-31 | $641,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2025 | — | $4.74M | $4.74M | $0.25 | 40.45M sh | −1.0% | — |
| FY2024 | — | $2.48M | $2.48M | — | 40.85M sh | +0.8% | — |
Pharmaceutical preparations
Oramed Pharmaceuticals Inc. is the 202nd largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
RNACCartesian Therapeutics, Inc.$2.8M92.8%4,658.6%$194.3MTRAWTraws Pharma, Inc.$2.8M1,134.5%328.7%$4.2MGOVXGeoVax Labs, Inc.$2.5M37.1%862.3%$1.1MKRSAKorsana Biosciences, Inc.$2.1M3.7%170.1%$1.4BDNTHDianthus Therapeutics, Inc.$2.0M67.3%7,973.3%$5.2B
ORMPOramed Pharmaceuticals Inc. (this company)$2.0M—3,202.5%$175.2M
LPCNLipocine Inc.$2.0M82.3%487.1%$17.9MBIOEBio Essence Corp$1.9M485.8%47.2%$19.0MRANIRani Therapeutics Holdings, Inc.$1.6M58.9%1,817.1%$75.6MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Oramed Pharmaceuticals Inc. · CIK 1176309 · Engraved from SEC EDGAR